Mifepristone And Misoprostol Regimen

US-MEC 2024 update, NuvaRing for adenomyosis, COCs & psychotropic meds, abortion bans & maternal health, adolescent abortion info

Answers for healthcare providers on routes of misoprostol administration and what they mean for medication abortion care.

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Ongoing support for forgoing Rh testing in early pregnancy, medication abortion before six weeks, provider bias on contraceptive counseling adolescents, and local anesthesia before procedural abortion.

Doctor-messengers are valuable communicators about abortion, impact of the shot on medication abortion efficacy, common misconceptions about IUDs, and precoital EC.

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

Young people’s concerns about birth control and fertility, expanding EPT and PrEP in the ED, spike in EC demand around the New Year, and abortion decision making.

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!